Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer
Active, not recruiting · NCT04837209 · Registry updated 2026-06-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2026-06-17 | NCT04837209 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| Massachusetts General Hospital | 758 |
| Sibley Memorial Hospital | 1 |
| University of Pennsylvania | 502 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University Medical Center | Durham | United States | 505 |
| Massachusetts General Hospital Cancer Center | Boston | United States | 178 |
| Sibley Memorial Hospital | Washington D.C. | United States | 121 |
| University of Pennsylvania Abramson Cancer Center | Philadelphia | United States | 14 |